Metabolic Disease Trials
Cross-source consensus on Metabolic Disease Trials from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Where it comes from
Highlighted claims
- The final sample included 444 industry-sponsored phase 1-3 metabolic disease trials. — Association between decentralised clinical trial adoption and trial duration: a retrospective cross-sectional study of metabolic disease trials
- Eligible metabolic disease trials focused on diabetes, obesity, and dyslipidaemia. — Association between decentralised clinical trial adoption and trial duration: a retrospective cross-sectional study of metabolic disease trials
- The study focused on metabolic diseases because DCTs are common in this area and trial designs are relatively standardised. — Association between decentralised clinical trial adoption and trial duration: a retrospective cross-sectional study of metabolic disease trials
- Metabolic diseases are suited to remote physiological monitoring such as blood glucose monitoring and wearable data collection. — Association between decentralised clinical trial adoption and trial duration: a retrospective cross-sectional study of metabolic disease trials